As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

  5/4/21  EyePoint Pharmaceuticals, Inc.    10-K/A     12/31/20   14:826K                                   Donnelley … Solutions/FA 
  5/3/21  EyePoint Pharmaceuticals, Inc.    NT 10-K    12/31/20    1:23K                                    Donnelley … Solutions/FA 
 3/12/21  EyePoint Pharmaceuticals, Inc.    10-K       12/31/20  108:13M                                    ActiveDisclosure/FA      
 2/11/21  Lurker Nancy                      5          Dir.,Off.²  1:19K  EyePoint Pharmaceuticals, Inc.    Donnelley Fin’l S… 06/FA 
 1/14/21  OcuMension Therapeutics           3          10% Owner²  2:12K  EyePoint Pharmaceuticals, Inc.    Sidley Austin LLP/FA     
 1/13/21  Liu Ye                            3          Director²   2:12K  EyePoint Pharmaceuticals, Inc.    Hogan Lovells US LLP     
  1/4/21  EyePoint Pharmaceuticals, Inc.    8-K:1,2,3,512/31/20   13:555K                                   ActiveDisclosure/FA      

____________
¹	Filing/Form Types:  -K
	3	Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 { The Filer is an Insider² of the Issuer }.
	5	Annual Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 5 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-K	Annual Report — Form 10-K.
	NT 10-K	Notice of a Late Filing of a Form 10-K Annual Report — Form 12b-25.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.